Adaptive Biotechnologies (ADPT) Gross Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Gross Margin of 73.6% for Q1 2026, down 1.3% sequentially from 74.58% in Q4 2025, and up 598.0% YoY from 10.54% in Q1 2025.
Adaptive Biotechnologies (ADPT) Gross Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Gross Margin data on file, last reported at 73.6% in Q1 2026.
- Quarterly Gross Margin rose 598.0% year-over-year to 73.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75.26% (up 1716.0% YoY) and the FY2025 annual result came in at 74.24%, up 2160.0% from the prior year.
- Gross Margin fell to 73.6% in Q1 2026 per ADPT's latest filing, from 74.58% in the prior quarter.
- The five-year high for Gross Margin was 80.68% in Q3 2025, with the low at 210.03% in Q2 2023.
- Average Gross Margin over 5 years is 45.31%, with a median of 56.89% recorded in 2024.
- Year-over-year, Gross Margin slumped 27974 bps in 2023 and surged 26299 bps in 2024.
- Adaptive Biotechnologies' Gross Margin stood at 57.03% in 2022, then jumped by 41 bps to 80.6% in 2023, then slumped by 32 bps to 54.54% in 2024, then surged by 37 bps to 74.58% in 2025, then dropped by 1 bps to 73.6% in 2026.
- Business Quant data shows ADPT's Gross Margin at 73.6% in Q1 2026, 74.58% in Q4 2025, and 80.68% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 63.35% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 99.91% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 53.95% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 32.64% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 58.68% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | 73.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.60% |
| Dec 31, 2025 | 74.58% |
| Sep 30, 2025 | 80.68% |
| Jun 30, 2025 | 69.43% |
| Mar 31, 2025 | 67.62% |
| Dec 31, 2024 | 54.54% |
| Sep 30, 2024 | 55.74% |
| Jun 30, 2024 | 52.97% |
| Mar 31, 2024 | 56.89% |
| Dec 31, 2023 | 80.60% |
| Sep 30, 2023 | 48.98% |
| Jun 30, 2023 | -210.03% |
| Mar 31, 2023 | 50.38% |
| Dec 31, 2022 | 57.03% |
| Sep 30, 2022 | 55.02% |
| Jun 30, 2022 | 69.72% |
| Mar 31, 2022 | 32.44% |
| Dec 31, 2021 | -59.56% |
| Sep 30, 2021 | 36.79% |
| Jun 30, 2021 | 39.71% |